The Asia Pacific veterinary diagnostics market was valued at US$ 744.78 million in 2022 and is expected to reach US$ 1,384.92 million by 2030; it is estimated to grow at a CAGR of 8.1% from 2022 to 2030.
Southeast Asia region is a hotspot for zoonotic illnesses due to factors including population growth and travel, deforestation, agricultural and meat production, wildlife consumption and commerce, and climate change. The last century has seen a number of zoonotic viral outbreaks in the region, ranging in size and scope. Notably, large outbreaks of the highly pathogenic avian influenza H5N1, the Chikungunya virus, and SARS have been reported, causing serious concern as well as significant health and economic effects, aside from the SARS-CoV-2 pandemic. According to the World Health Organization (WHO), rabies occurs in more than 150 countries and causes tens of thousands of deaths yearly, particularly in Asia and Africa. Thus, the rising rabies globally increases the need for diagnoses of the illnesses, contributing to the growth of the veterinary diagnostics market. Also, the rising prevalence of zoonotic diseases globally accelerates the demand for veterinary diagnostics.
Regionally and globally, zoonotic diseases are recognized closely by the Food and Agriculture Organization of the United Nations (FAO), the World Organisation for Animal Health (OIE), and WHO working in Asia Pacific. As per the Accelerating One Health in Asia and the Pacific report, the concept and importance of One Health approach is gaining significant attention due to ecosystem degradation, biodiversity loss, and climate change putting public health challenges at the human-animal-environment interface in Asia Pacific. Therefore, the adoption of One Health approaches can assist Asia Pacific countries to progress through multiple sectors and stakeholders' engagement. These engagements are conducted in terms of human health, terrestrial and aquatic animal health, and food production to ultimately improve outcomes essential to achieve the Sustainable Development Goals (SDGs).
Based on product, the Asia Pacific veterinary diagnostics market is bifurcated into instruments and consumables. The instruments segment held a larger share in 2022.
By technology, the Asia Pacific veterinary diagnostics market is segmented into immunodiagnostics, clinical biochemistry, hematology, molecular diagnostics, and other veterinary diagnostic technologies. The immunodiagnostics segment held the largest share in 2022. The immunodiagnostics segment is further subsegmented into lateral flow assays, ELISA, immunoassay, allergen-specific immunodiagnostics test, and other immunodiagnostics. The clinical biochemistry segment is further subsegmented into clinical chemistry analysis, glucose monitoring, and blood gas and electrolyte.
By disease type, the Asia Pacific veterinary diagnostics market is segmented into infectious disease and non-infectious diseases. The infectious diseases segment held the largest share in 2022.
By animal type, the Asia Pacific veterinary diagnostics market is bifurcated into livestock animals and companion animals. The companion animals segment held a larger share in 2022. The livestock animals segment is further subsegmented into cattle, pigs, poultry, and other livestock animals. The companion animals segment is further subsegmented into dogs, cats, horses, and other companion animals.
By end user, the Asia Pacific veterinary diagnostics market is segmented into veterinary hospitals and clinics, animal diagnostic laboratories, and veterinary research institutes and universities. The companion animals segment held the largest share in 2022.
Based on country, the Asia Pacific veterinary diagnostics market is segmented into China, Japan, India, Australia, South Korea, and the Rest of Asia Pacific. China dominated the Asia Pacific veterinary diagnostics market in 2022.
FUJIFILM Holdings Corp, Heska Corp, Idexx Laboratories Inc, Merck Animal Health, Neogen Corp, Randox Laboratories Ltd, Thermo Fisher Scientific Inc, Virbac SA, and Zoetis Inc are some of the leading companies operating in the Asia Pacific veterinary diagnostics market.
Rising Prevalence of Zoonotic Disease Fuel Asia Pacific Veterinary Diagnostics Market
Zoonotic diseases cause illnesses not only in animals but also in humans. These infections can cause from mild to severe conditions. As per the Council on Foreign Relations, zoonoses cause 2.5 billion illnesses and 2.7 million deaths each year globally, accounting for 60% of known infectious diseases and 75% of new or emerging infectious diseases. Also, according to Centers for Disease Control and Prevention, in 2023, 6 out of every 10 infectious diseases in humans are spread by animals, and 3 of 4 new or emerging infectious diseases are transferred by animals. Further, dogs contribute to 99% of all rabies transmissions to humans and are a major source of human rabies deaths. The economic burden due to dog-mediated rabies is estimated to be US$ 8.6 billion/year globally. According to the World Health Organization (WHO), rabies occurs in more than 150 countries and causes tens of thousands of deaths yearly, particularly in Asia and Africa. The International Livestock Research Institute estimates that 13 zoonoses cause 2.4 billion cases of human disease and 2.2 million deaths annually in India. The International Livestock Research Institute estimates that 13 zoonoses cause 2.4 billion cases of human disease and 2.2 million deaths annually in India.Southeast Asia region is a hotspot for zoonotic illnesses due to factors including population growth and travel, deforestation, agricultural and meat production, wildlife consumption and commerce, and climate change. The last century has seen a number of zoonotic viral outbreaks in the region, ranging in size and scope. Notably, large outbreaks of the highly pathogenic avian influenza H5N1, the Chikungunya virus, and SARS have been reported, causing serious concern as well as significant health and economic effects, aside from the SARS-CoV-2 pandemic. According to the World Health Organization (WHO), rabies occurs in more than 150 countries and causes tens of thousands of deaths yearly, particularly in Asia and Africa. Thus, the rising rabies globally increases the need for diagnoses of the illnesses, contributing to the growth of the veterinary diagnostics market. Also, the rising prevalence of zoonotic diseases globally accelerates the demand for veterinary diagnostics.
Asia Pacific Veterinary Diagnostics Market Overview
According to the Department of Agriculture, Fisheries and Forestry report, the Japanese Encephalitis (JE) virus-spread by mosquitoes-negatively affects the reproductive performance of pigs; it also causes viral encephalitis in humans. In 2022, Australia experienced an outbreak of JEV in domestic pigs, accounting for detections in over 80 piggeries in Queensland, New South Wales (NSW), Victoria, and South Australia. In March 2022, the first JEV outbreak in Australia resulted in the declaration of a Communicable Disease Incident of National Significance (CDINS). Australia is well placed to continue to manage the risk of JEV. For instance, in June 2023, the CDINS declared JEV as an outbreak, and the nation is well prepared to handle future outbreaks with a dedicated response. The Public Library of Science (PLoS) reports that the incidence of infectious diseases has increased in Asia Pacific since 2020. For example, increased encroachment of farms on wildlife habitats has resulted in the reach of livestock and wild animals with severe consequences of accelerating emerging infectious/zoonotic diseases from wild animals. Therefore, the Asia Pacific strategy for emerging diseases has benefitted from controlling the prevalence of infectious diseases in animals.Regionally and globally, zoonotic diseases are recognized closely by the Food and Agriculture Organization of the United Nations (FAO), the World Organisation for Animal Health (OIE), and WHO working in Asia Pacific. As per the Accelerating One Health in Asia and the Pacific report, the concept and importance of One Health approach is gaining significant attention due to ecosystem degradation, biodiversity loss, and climate change putting public health challenges at the human-animal-environment interface in Asia Pacific. Therefore, the adoption of One Health approaches can assist Asia Pacific countries to progress through multiple sectors and stakeholders' engagement. These engagements are conducted in terms of human health, terrestrial and aquatic animal health, and food production to ultimately improve outcomes essential to achieve the Sustainable Development Goals (SDGs).
Asia Pacific Veterinary Diagnostics Market Segmentation
The Asia Pacific veterinary diagnostics market is segmented based on product, technology, disease type, animal type, end user, and country.Based on product, the Asia Pacific veterinary diagnostics market is bifurcated into instruments and consumables. The instruments segment held a larger share in 2022.
By technology, the Asia Pacific veterinary diagnostics market is segmented into immunodiagnostics, clinical biochemistry, hematology, molecular diagnostics, and other veterinary diagnostic technologies. The immunodiagnostics segment held the largest share in 2022. The immunodiagnostics segment is further subsegmented into lateral flow assays, ELISA, immunoassay, allergen-specific immunodiagnostics test, and other immunodiagnostics. The clinical biochemistry segment is further subsegmented into clinical chemistry analysis, glucose monitoring, and blood gas and electrolyte.
By disease type, the Asia Pacific veterinary diagnostics market is segmented into infectious disease and non-infectious diseases. The infectious diseases segment held the largest share in 2022.
By animal type, the Asia Pacific veterinary diagnostics market is bifurcated into livestock animals and companion animals. The companion animals segment held a larger share in 2022. The livestock animals segment is further subsegmented into cattle, pigs, poultry, and other livestock animals. The companion animals segment is further subsegmented into dogs, cats, horses, and other companion animals.
By end user, the Asia Pacific veterinary diagnostics market is segmented into veterinary hospitals and clinics, animal diagnostic laboratories, and veterinary research institutes and universities. The companion animals segment held the largest share in 2022.
Based on country, the Asia Pacific veterinary diagnostics market is segmented into China, Japan, India, Australia, South Korea, and the Rest of Asia Pacific. China dominated the Asia Pacific veterinary diagnostics market in 2022.
FUJIFILM Holdings Corp, Heska Corp, Idexx Laboratories Inc, Merck Animal Health, Neogen Corp, Randox Laboratories Ltd, Thermo Fisher Scientific Inc, Virbac SA, and Zoetis Inc are some of the leading companies operating in the Asia Pacific veterinary diagnostics market.
Table of Contents
1. Introduction
2. Executive Summary
3. Research Methodology
4. Asia Pacific Veterinary Diagnostics Market - Key Industry Dynamics
5. Veterinary Diagnostics Market - Asia Pacific Market Analysis
6. Asia Pacific Veterinary Diagnostics Market - Revenue and Forecast to 2030 - by Product
7. Asia Pacific Veterinary Diagnostics Market - Revenue and Forecast to 2030 - by Technology
8. Asia Pacific Veterinary Diagnostics Market - Revenue and Forecast to 2030 - by Animal Type
9. Asia Pacific Veterinary Diagnostics Market - Revenue and Forecast to 2030 - by Disease Type
10. Asia Pacific Veterinary Diagnostics Market - Revenue and Forecast to 2030 - by End User
11. Asia Pacific Veterinary Diagnostics Market - Revenue and Forecast to 2030 - Country Analysis
12. Industry Landscape
13. Company Profiles
14. Appendix
List of Tables
List of Figures
Companies Mentioned
- FUJIFILM Holdings Corp
- Heska Corp
- Idexx Laboratories Inc
- Merck Animal Health
- Neogen Corp
- Randox Laboratories Ltd
- Thermo Fisher Scientific Inc
- Virbac SA
- Zoetis Inc
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 136 |
| Published | February 2024 |
| Forecast Period | 2022 - 2030 |
| Estimated Market Value in 2022 | 744.78 Million |
| Forecasted Market Value by 2030 | 1384.92 Million |
| Compound Annual Growth Rate | 8.1% |
| Regions Covered | Asia Pacific |
| No. of Companies Mentioned | 9 |
